Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

SHA:600976 Revenue

Jianmin Pharmaceutical Group had revenue of 747.33M CNY in the quarter ending September 30, 2025, a decrease of -14.27%. This brings the company's revenue in the last twelve months to 3.18B, down -20.15% year-over-year. In the year 2024, Jianmin Pharmaceutical Group had annual revenue of 3.50B, down -16.81%.

• Revenue (ttm): 3.18B
• Revenue Growth: -20.15%
• P/S Ratio: 1.59
• Revenue / Employee: 1.35M
• Employees: 2,345
• Market Cap: 5.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.50B	-708.17M	-16.81%
Dec 31, 2023	4.21B	572.35M	15.72%
Dec 31, 2022	3.64B	341.37M	10.35%
Dec 31, 2021	3.30B	843.43M	34.34%
Jan 1, 2021	2.46B	217.06M	9.69%